Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Performance characteristics of the ARCHITECT Active-B12 (Holotranscobalamin) assay.

Merrigan SD, Owen WE, Straseski JA.

Clin Lab. 2015;61(3-4):283-8.

PMID:
25974994
2.

Intrinsic factor blocking antibody interference is not detected in five automated cobalamin immunoassays.

Merrigan SD, Yang DT, Straseski JA.

Am J Clin Pathol. 2014 May;141(5):702-5. doi: 10.1309/AJCPPWHSB94FTOGU.

PMID:
24713742
3.

Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis.

Anderson NW, Klein DM, Dornink SM, Jespersen DJ, Kubofcik J, Nutman TB, Merrigan SD, Couturier MR, Theel ES.

Clin Vaccine Immunol. 2014 May;21(5):732-6. doi: 10.1128/CVI.00041-14. Epub 2014 Mar 19.

4.

A spectrophotometric method to precisely determine endpoint titers in complement fixation assays.

Welch RJ, Merrigan SD, Delgado JC.

J Clin Lab Anal. 2012 May;26(3):190-3. doi: 10.1002/jcla.21509.

PMID:
22628235
5.

Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.

Merrigan SD, Welch RJ, Litwin CM.

Clin Vaccine Immunol. 2011 Apr;18(4):615-20. doi: 10.1128/CVI.00450-10. Epub 2011 Feb 9.

Supplemental Content

Loading ...
Support Center